Professional Documents
Culture Documents
Department of Hematology Covid-19 Health Checkup (Post Recovery)
Department of Hematology Covid-19 Health Checkup (Post Recovery)
DEPARTMENT OF HEMATOLOGY
COVID-19 HEALTH CHECKUP (POST RECOVERY)
Test Name Result Unit Bio. Ref. Interval Method
Page 1 of 7
DEPARTMENT OF HEMATOLOGY
COVID-19 HEALTH CHECKUP (POST RECOVERY)
Test Name Result Unit Bio. Ref. Interval Method
Page 2 of 7
DEPARTMENT OF BIOCHEMISTRY
COVID-19 HEALTH CHECKUP (POST RECOVERY)
Test Name Result Unit Bio. Ref. Interval Method
General Information:
Preanalytical issues such as high-protein intake and increased muscle bulk may lead to elevated creatinine levels not representative of
actual renal function in an individual. Likewise, serum creatinine as a marker of renal function is often unreliable in the those with
decreased muscle bulk such as the elderly, amputees and is individuals affected by muscular dystrophy.
Page 3 of 7
DEPARTMENT OF BIOCHEMISTRY
COVID-19 HEALTH CHECKUP (POST RECOVERY)
Test Name Result Unit Bio. Ref. Interval Method
Genral Information:
High coffee consumption and heavy smoking were both associated with low total protein and albumin levels. High coffee
consumption lowered serum AST levels, independently. Because smoking, coffee and alcohol drinking habits showed strong
interactions among each other, the association of those habits and LFTs should be carefully analyzed and interpreted.
Page 4 of 7
DEPARTMENT OF BIOCHEMISTRY
COVID-19 HEALTH CHECKUP (POST RECOVERY)
Test Name Result Unit Bio. Ref. Interval Method
Page 5 of 7
DEPARTMENT OF SEROLOGY
COVID-19 HEALTH CHECKUP (POST RECOVERY)
Test Name Result Unit Bio. Ref. Interval Method
Test Result – Non-Reactive
A Non-Reactive test result means that the IgG antibodies to the virus that causes COVID-19 were not found in your sample. However, it is possible for this test to give a
Non-Reactive result that is incorrect (false Non-Reactive) in some people with COVID-19 infection.
A Non-Reactive result may occur if you are tested early in your illness and your body hasn’t had time to produce IgG antibodies to infection. This means that you could
possibly still have COVID-19 even though the test is Non-Reactive. If this is the case, your doctor/healthcare provider will consider the test result together with all other
aspects of your medical history (such as symptoms, possible exposures, and geographical location of places you have recently traveled) in deciding how to care for you.
It is important that you work with your doctor/healthcare provider to help you understand the next steps you should take.
Test Result – Reactive
A Reactive test result indicates that IgG antibodies to SARS-CoV-2 were detected, and you are likely to have or previously had COVID-19 and that you have developed an
antibody response to the virus.
The referring doctor/healthcare provider will work with you to determine how best to care for you based on the test results along with other factors of your medical
history, including any previous symptoms, possible exposure to COVID-19, and the location of places you have recently traveled.
Clinical Indications: The Anti-SARS-CoV-2 IgG test is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection. The
Anti-SARS-CoV-2 IgG test should not be used to diagnose acute SARS-CoV-2 infection. Results are for the detection of SARS-CoV-2 antibodies. IgG antibodies to SARS-CoV-2 are generally detectable in
blood several days after initial infection, although the duration of time antibodies are present post-infection is not well characterized. Individuals may have detectable virus present for several weeks
following seroconversion.
Experts believe that the Positive Predictive Value (PPV) is the most important metric of accuracy for COVID-19 antibody tests based on the current utilities. PPV is the probability that the test
accurately detects the antibodies to COVID-19 and is dependent on the prevalence of the disease. High specificity tests provide a high PPV. Specificities closer to 100% yield high PPV in low or
high prevalence areas—so are ideal as prevalence changes. The VITROS® Immunodiagnostic Products Anti-SARS-CoV-2 IgG assay has a specificity of 100%
--------------------------------------------
Test Performed on VITROS 5600 & XT 7600 System using Anti-SARS-CoV-2 IgG (US-FDA EUA Approved).
---------------------------------------------
Page 6 of 7
Page 7 of 7